Rallybio Corp. (RLYB)

16.90 +0.02 (+0.15%) USD  |  NASDAQ  |  Sep 04, 16:00
16.90 0.00 (0.00%) After-Hours: 20:00
More

Rallybio Cash and Short Term Investments (Annual) : 54.74M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for RLYB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 54.74M
December 31, 2024 65.51M
December 31, 2023 109.93M
December 31, 2022 168.99M
Date Value
December 31, 2021 175.33M
December 31, 2020 140.23M
December 31, 2019 19.46M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Q32 Bio, Inc. 48.30M
Beam Therapeutics, Inc. 1.245B
C4 Therapeutics, Inc. 248.54M
Cullinan Therapeutics, Inc. 377.90M
Arrowhead Pharmaceuticals, Inc. 919.37M